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SUMMARY
Directed conversion of mature human cells, as from
fibroblasts to neurons, is of potential clinical utility
for neurological disease modeling as well as cell
therapeutics. Here, we describe the efficient genera-
tion of human-induced neuronal (hiN) cells from
adult skin fibroblasts of unaffected individuals and
Alzheimer’s patients, using virally transduced tran-
scription regulators and extrinsic support factors.
hiN cells fromunaffected individuals displaymorpho-
logical, electrophysiological, and gene expression
profiles that typify glutamatergic forebrain neurons
and are competent to integrate functionally into the
rodent CNS. hiN cells from familial Alzheimer disease
(FAD) patients with presenilin-1 or -2 mutations
exhibit altered processing and localization of amyloid
precursor protein (APP) and increased production of
Ab, relative to the source patient fibroblasts or hiN
cells from unaffected individuals. Together, our find-
ings demonstrate directed conversion of human
fibroblasts to a neuronal phenotype and reveal cell
type-selective pathology in hiN cells derived from
FAD patients.
INTRODUCTION
Mature mammalian cells can be reprogrammed to alternative
fates by introduction of lineage-specific transcription regulators.
For instance,Myod1 expression has been shown to induce amy-
ocyte phenotype in fibroblast cultures (Davis et al., 1987). Simi-
larly, transduction of a set of pluripotency regulators is sufficient
to convert skin fibroblasts to induced pluripotency stem (iPS)
cells with embryonic stem cell characteristics (Takahashi et al.,
2007; Takahashi and Yamanaka, 2006; Yu et al., 2007). iPS cell
technology has fueled much excitement in regenerative medi-
cine, as these cells could be differentiated to generate ‘‘replace-
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also been proposed to serve as neurodegenerative disease
models (Abeliovich and Doege, 2009).
A limitation to human iPS cell technology is that it remains inef-
ficient (less than 1% of cells are typically reprogrammed) and
time intensive; iPS cell generation and subsequent differentiation
to a neuronal phenotype can take 1–2 months each. Further-
more, the pluripotent state is associated with tumorigenesis
and genetic instability (Pera, 2011). Recently, the directed con-
version of rodent skin fibroblasts to a neuronal fate was re-
ported, utilizing a set of three forebrain transcription regulators
and apparently circumventing the production of a pluripotent
intermediate state (Vierbuchen et al., 2010). Here, we describe
the directed conversion of adult human fibroblasts to a neuronal
phenotype, termed human-induced neuronal (hiN) cells. To vali-
date the approach, we show that hiN cells display electrophysi-
ological properties of forebrain glutamatergic neurons and can
integrate into mammalian CNS circuitry.
We further apply hiN cell technology to a panel of skin fibro-
blasts derived from patients with sporadic or familial forms of
Alzheimer’s disease (AD) and examine AD-associated neuronal
pathologies. AD patients typically present with age-associated
cognitive dysfunction, including reduced short-term (episodic)
memory and spatial disorientation. These cognitive deficits are
associated with neuronal and synaptic loss that is most promi-
nent within the medial temporal lobe of the cerebral cortex and
the hippocampus (Alzheimer, 1907). Additional pathological fea-
tures of AD include extracellular amyloid plaques composed
largely of Ab fragments of amyloid precursor protein (APP) and
intraneuronal tangles of Tau-paired helical filaments (Hardy
and Selkoe, 2002). Rare, autosomal, dominantly inherited fa-
milial forms of AD (FAD) are caused by mutations in APP or in
the two presenilin genes (presenlin-1 and –2, or PSEN1 and
PSEN2) that encode components of the g-secretase enzyme
complex that is required for APP cleavage to Ab (Hardy and
Selkoe, 2002).
The amyloid hypothesis of AD, which is based on the afore-
mentioned pathological and genetic findings, proposes that
modified cleavage of APP by b-secretase and g-secretase leads
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to the generation of a pathogenic Ab42 fragment. Consistent
with this hypothesis, expression of disease-associated PSEN
FAD mutations in cell and animal models leads to preferential
accumulation of Ab42 isoform relative to an Ab40 isoform. None-
theless, basic questions regarding the pathogenicmechanism of
PSEN FAD mutations remain (De Strooper and Annaert, 2010;
Shen and Kelleher, 2007). For instance, although PSEN FAD
mutations increase relative Ab42 production, they paradoxically
reduce total g-secretase activity, at least in cell-free and heterol-
ogous cell overexpression systems (Bentahir et al., 2006; Walker
et al., 2005). The potential role of reduced g-secretase activity in
the disease process remains controversial. As the majority of
studies to date rely on exogenous overexpression of PSEN
FAD mutations in tumor cells, transgenic mice, or skin fibro-
blasts, the impact of endogenous PSEN FADmutations on func-
tional human patient neurons remains unclear. Moreover, why
mutations in the broadly expressed PSEN-1 and -2 genes lead
to a selective neuronal pathology is an open question.
RESULTS
Phenotypic Characterization of hiN Cells
We initially attempted to convert human adult skin fibroblasts
(STC0022; see Table S1 available online) to hiN cells by viral
cotransduction of a combination of three transcription regula-
tors—Ascl1, Brn2, and Myt1l—that were shown to be effective
for reprogramming of rodent cells (Vierbuchen et al., 2010).
These attempts were unsuccessful and led to prominent apo-
ptotic cell death. Viral cotransduction of a larger set of forebrain
transcription regulators—Brn2, Myt1l, Zic1, Olig2, and Ascl1, in
the presence of neuronal survival factors (including brain-derived
neurotrophic factor [BDNF], neurotrophin-3 [NT3], and glial-
conditioned media [GCM]), resulted in the generation of cells
with a neuronal morphology (human-induced neuronal cells, or
hiN cells) (Figures 1A–1N). Three weeks after viral transduction,
hiN cells were positive for neuronal markers, including Tuj1,
MAP2, Tau1, NeuN, NCAM, and Neurofilament-160 kd (Figures
1B–1G and 1J–1N and Figure S1). Such cells were never
observed in fibroblast cultures transduced with control vector
only (Figures 1H and 1I). Cell staining with the astroglial marker
glial fibrillary acidic protein (GFAP) was not detected in hiN cell
cultures (Figure S1). More than 90% of MAP2-positive cells
were positive for the neocortical glutamate neuron marker Tbr1
(Figure 1K), and theseTbr1-positive cells did not express the
fibroblast marker, fibroblast-specific protein-1 (FSP1; Figure 1L).
Approximately half of the MAP2-positive cells were positive for
the mature glutamatergic neuron marker vesicular glutamate
transporter-1 (vGLUT1) in a stereotypical punctate pattern (Fig-
ure 1M). Only rare MAP2-positive cells (less than 1%) displayed
the GABAergic neuron marker, glutamic acid decarboxylase-65
(GAD65; Figure 1N).
We applied our hiN cell conversion protocol to a panel of nine
adult human skin fibroblast lines in total (see Table S1). Quanti-
tative analysis indicates that conversion efficiency of fibroblasts
to MAP2-positive hiN cells across these lines ranged from 7.1%
to 8.9% (as a percentage of input fibroblasts; n = 3 per group).
After accounting for cell attrition during the 3 week culture,
28.4%–36.1% of the surviving cells were MAP2 positive (Fig-
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cells were also positive for vGLUT1 (Figure 1P).
Time course analysis indicated that MAP2- and vGLUT1-posi-
tive hiN cells first appear by day 7 after viral vector transduction
and that maximal conversion occurs by 21 days (Figure 2A). After
21 days, hiN cell number decreased, and this was accompanied
by evidence of apoptosis (Figure 2A and Figures S2C–S2G). Re-
maining cells displayed progressively elongated processes, as
expected (Figure S2B). To determine the minimal factors that
are necessary and sufficient to generate hiN cells, we removed
individual transcription factor vectors or extrinsic components
from the conversion protocol. These data indicated that Ascl1
and Brn2 are essential for the process, whereas Zic1 and Myt1l
modify efficiency, and Oligo2 appears to be redundant (Fig-
ure 2B). After transduction with viral factor cocktails, converted
cells maintained expression of the extrinsic virally encoded
Ascl1, Brn2, and Myt1l transcription factors, as determined by
RT-PCR analysis, whereas extrinsic Zic1 expression was main-
tained only in a subset of cultures (Figure S2A). Maintenance of
exogenous factor expression may have contributed to the
apoptotic loss of hiN cells with extended culturing. Of the tested
soluble extrinsic factors, only BDNF appeared essential for
production of MAP2+/vGLUT1+ cells (Figure 2B and Figure S2D).
A single polycistronic lentivirus vector harboring the genes
Ascl1, Brn2, and Zic1 (ABZ vector) was sufficient for the conver-
sion process (Figure 2C and Figures S2K–S2N). ABZ vector-
mediated conversion was highly efficient and could be further
enhanced by adding Myt1l (Figure 2C and Figures S2O–S2V).
Specifically, 62% ± 6% of the adult human fibroblasts that
were transducedwith the ABZ vector and 85% ± 15%of the cells
that were transduced with the ABZ vector and Myt1 acquired
a MAP2-positive neuronal morphology phenotype (Figure 2C
and Figures S2L–S2Q). These hiN cells expressed additional
neuron markers, including Tau-1, Tuj1, Tbr1, and vGLUT1
(Figures S2R–S2V).
To further characterize the hiN cell phenotype, we performed
whole-transcriptome gene expression profiling on neurons that
were purified from hiN cell cultures. hiN cell cultures were sub-
jected to fluorescence-activated cell sorting (FACS; Figures
S2H–S2J) to select for neural cell adhesion molecule (NCAM,
a marker for mature neurons as well as some neural progeni-
tors)-positive cells. RNA preparations from FACS-purified hiN
cells, total (‘‘mixed’’) cultures, and unconverted fibroblasts
were then analyzed for genome-wide expression (Table S2).
Hierarchical clustering analysis demonstrated that the transcrip-
tome profiles of purified hiN cells weremore similar to each other
than to the originating fibroblasts (Figure 2D). Using gene
ontology (GO) functional annotation, we identified genes that
are most enriched within the purified hiN cell samples relative
to the fibroblast samples (upregulated by at least 4-fold with
a significance analyses of microarrays false discovery rate
[FDR] cutoff of less than 25%). Consistent with a neuronal phe-
notype, the most highly enriched, functionally annotated gene
sets in the purified hiN samples included ‘‘axonal projection’’
and ‘‘neuronal differentiation’’ genes (Figures 2E–2G and Table
S2). Finally, we performed hierarchical clustering to broadly
compare hiN cell gene expression profiles to those seen in
human neurons (isolated from postmortem brain samples) and
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Figure 1. hiN Cells Display a Forebrain Glutama-
tergic Neuron Phenotype
(A) Schematic of the conversion method. Top panels show
phase contrast images of human skin fibroblast (left) or hiN
cell (right) cultures. TFs, lentiviral vectors encoding tran-
scription regulators Ascl1, Brn2, Myt1l, Olig2, and Zic1;
NTs, neurotrophins BDNF and NT3; GCM, glial-condi-
tioned medium.
(B–G) Neuronal marker analysis of hiN cell cultures.
Human skin fibroblasts (STC0022; see Table S1) were
transduced with the five transcription regulators, cultured
for 3 weeks as in (A), and subsequently immunostained
with antibodies specific to Tuj1 (B and E; in red), MAP2 (C;
in green), or Tau-1 (F; in green). (D) Merged image of (B)
and (C). (G) Merged image of (E) and (F). Arrows in (F)
indicate the typical distal enrichment pattern of Tau1
antibody immunostaining.
(H and I) Absence of neuronal markers in lentiviral vector-
only transduced fibroblast cultures. Human skin fibro-
blasts (line STC0022) transduced with control lentiviral
vector only were cultured for 3 weeks as above and ana-
lyzed for expression of Tuj1 (in red, H) and MAP2 (in green,
H). Cultures were counterstained with the nuclear marker
4,6-diamidino-phenylindole (I, DAPI, in blue). Neuronal
marker expression was not detected.
(J) Costaining of hiN culture with the neuronal nuclear
marker NeuN (red) and MAP2 (green) is shown.
(K and L) Forebrain marker expression in hiN cells. The
majority of hiN cells expressed the neocortical glutamate
neuron nuclear marker Tbr1 (K and L, in red) along with
MAP2 (K, in green). In contrast, Tbr1-positive hiN cells
were not stained by the fibroblast marker fibroblast-
specific protein-1 (L, FSP1, in green). Arrows in (L) de-
marcate Tbr1-positive nuclei.
(M) A majority of Tuj-1-positive hiN cells expressed the
glutamatergic neuron marker vGLUT1 (in green). Inset
shows magnified view of the boxed region; arrows indi-
cate the typical vGLUT1-positive punctate pattern.
(N) Only rare (<1%, in green) hiN Tau-1-positive cells also
stained positively for GAD65 (in red).
(O and P) Quantification of MAP2- and vGLUT1-positive
cells in hiN cell cultures derived from a panel of nine
human fibroblast lines. (O) Black bars indicate the percent
of total cells that are MAP2-positive cells with extended
processes (at least 3-fold greater than soma diameter, as
in F). (P) Black bars indicate the percent of MAP2-positive
cells that stain for the glutamatergic neuron marker
vGLUT1 as in (M). n = 3 wells for each group; data are
presented as mean ± SEM.
Scale bars: (J) and inset of (M), 10 mm; (B–G), (K–L), and
(N), 20 mm; (A), (H), (I), and (M), 40 mm. See also Figure S1
and Table S1.R
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clustered most closely with CNS neurons rather than fibroblasts,
astrocytes, neural progenitors, or pluripotent ES or iPS cells
(Figure S3).Cell 146,hiN Cell Reprogramming Is Directed
Consistent with the idea that the hiN cell pheno-
type can be achieved without neuronal progen-
itor intermediates, expression of the progenitor
markers Sox2 and Pax6 was not apparent
during hiN cell reprogramming (Figures 3A–3Cand 3E–3G). Expression of Nestin, which is associated with
neuronal progenitors but also functionsmore generally as a cyto-
skeleton regulator during morphological cell changes (Gilyarov,
2008), appeared transiently in a subpopulation of cells (<10%;359–371, August 5, 2011 ª2011 Elsevier Inc. 361
Figure 2. Further Description of hiN Cell Conversion: Essential Factors and Transcriptome Analysis
(A) Temporal profile of hiN cell conversion. MAP2- or vGLUT1-positive cells were quantified at indicated time points after transduction with conversion factor
vectors (5F, indicated as blue or red line) or empty vector (Empty, green or purple line). The number of MAP2- (diamond) and vGLUT1-positive (square) cells
peaked at 21 days after 5F transduction, whereas such cells were not apparent with empty vector. n = 3 at each time point; data are presented as mean ± SEM.
(B) Required factors in hiN cell conversion. Fibroblasts were transduced with the 5-factor (5F) cocktail as above or with factor mixes lacking the indicated
individual factors. Bar graphs indicate the number of vGLUT1-positive cells at 3 weeks after transduction, as a percent of 5F transduction. GCM, glial-conditioned
media. n = 3 per group. Results represent the mean ± SEM.
(C) Fibroblasts were transduced with a polycistronic vector harboring Ascl1, Brn2, and Zic1 (ABZ-polycistronic) alone or in combination with aMyt1l vector. The
percentage of Ascl1-positive cells per total cell number (Hoechst-positive nuclei, blue bars) reflects the transduction efficiency. The percentage ofMAP2-positive
hiN cells of transduced Ascl1-positive cells (red bars) reflects the hiN cell conversion efficiency. n = 3 per group. Results represent the mean ± SEM.
(D) Dendrogram presenting the hierarchical clustering of gene expression array profiles as measured by Human Genome U133 Plus 2.0 Arrays (Affymetrix).
Complete linkage hierarchical clustering analysis was performed using Pearson’s correlation metric. The dendrogram includes individual samples from FACS-
sorted hiN cells (iN_FACS), unsorted hiN cell cultures (iN_Mix), or the original fibroblasts (Fibro). Samples are labeled as to the fibroblast of origin (see Table S1).
hiN cell preparations clustered together, rather than with the originating fibroblast preparations.
(E and F) The five most significantly enriched gene ontology (GO) categories among the genes upregulated (E) or downregulated (F) in the context of hiN cell
conversion are presented. Expression data were analyzed using a false discovery rate of less than 25% and a log-ratio threshold of > 2. Nominal p values are
listed.
(G) Heat map specifying the genes and expression values within the GO category ‘‘neuron projection’’ as in (E). Relative expression levels of individual genes
(as labeled on rows) are presented from low (green) to high (red) as per the color chart bar at the bottom. Cell samples are labeled as per (D).
See also Figure S2, Figure S3, and Table S2.
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differentiation of human iPS cells to a neural progenitor state
led to the robust accumulation of Sox2-positive, Pax6-positive,
and Nestin-positive progenitors, as expected (Figures 3D, 3H,
and 3L). RNA expression profiling by real-time quantitative RT-
PCR similarly indicated that expression of neuronal progenitor
markers such as FOXG1 and OTX2 was absent from hiN cell
cultures (Figure 3P).
Physiological Properties of hiN Cells
The majority of hiN cells displayed typical neuronal Na+, K+, and
Ca2+ channel properties as assessed by patch-clamp recordings
of cells at days 21–28 of culture. Specifically, TTX-sensitive Na+
currents were characterized by a typical current density-voltage
relationship (Figures 4A and 4B; confirmed in 18 of 22 cells
R362 Cell 146, 359–371, August 5, 2011 ª2011 Elsevier Inc.analyzed). Outward K+ currents, inhibited in the presence of
intracellular cesium (Cs+), were readily apparent (Figures 4C
and 4D; confirmed in 14 of 16 cells analyzed). Calcium channel
function, measured using Barium (Ba2+) as the charge carrier,
displayed typical neuronal characteristics (Figure 4E; confirmed
in 3 of 4 cells analyzed). Consistent with such channel properties,
most hiN cells were able to fire at least one action potential in
response to depolarizing current injections in current clamp
mode (Figure 4F; 9 of 10 cells analyzed). Furthermore, upon
termination of hyperpolarizing pulses, cells displayed a typical
rebound spike (Figure 4F). Passive membrane properties were
also consistent with an in vitro neuronal phenotype, with a resting
membrane potentials ranging from 67 mV to 32 mV (average
52 mV; n = 17), membrane time constant (t) ranging from 1.00
to 0.30 ms, membrane resistance (Rm) ranging from 0.12 to
Figure 3. hiN Cell Reprogramming Is Directed
(A–H) Progenitor markers are not detected in hiN cell cultures. Sox2 (A–C)
and Pax6 (E–G) expression were not detected during hiN cell repro-
gramming at 3, 7, and 21 days after transduction. In contrast, human iPSC
cultures differentiated toward a neuroblast stage (IPS-N; D and H) dis-
played prominent intranuclear expression of the factors. Scale bar, 20 mm.
(I–N) Nestin is transiently expressed in a subset of cells within hiN cell
cultures (I–K), albeit less robustly than in iPS-N cells (L). Staining was not
apparent in empty vector-transduced cells (M and N).
(O) Temporal profile of Nestin-positive cells in hiN cell cultures or empty
vector-transduced skin fibroblasts. n = 3 at each time point. *p < 0.05 by
ANOVA with Bonferroni correction. Results represent the mean ± SEM.
(P) Quantitative real-time RT-PCR analysis of neural progenitor marker
gene expression in hiN cell cultures at 0, 7, or 21 days after transduction as
indicated or in iPSC-N cells. Expression levels are normalized to GAPDH;
error bars represent the standard error of themean (SEM); n > 9 per group.
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evaluated g-aminobutyric acid (GABA)-ergic and glutamatergic
ligand-gated ion channel activity in hiN cells. hiN cells responded
to exogenous puff application of glutamate or GABA, displaying
typical depolarizing and hyperpolarizing currents, respectively
(Figures 4G–4J; 7 of 7 cells analyzed). Finally, to provide func-
tional evidence that hiN cells possess elements of the intrinsic
machinery for synaptic vesicle release, we quantified local
calcium transients within axon-like processes in the context of
membrane step depolarization (using the fluorescent calcium
indicator Oregon Green-BAPTA [OG-1]). Highly localized, depo-larization-evoked fluorescence intensity changes were
apparent within the axon-like processes of hiN cells (Fig-
ure 4K; seen in 6 of 10 cells), which are thought to represent
putative synaptic release sites (Forti et al., 2000).
hiN Cells Can Integrate into Neuronal Circuitry
In Vitro and In Vivo
Wedid not observe spontaneous activity that is suggestive of
neuronal connectivity in hiN cells voltage clamped at70mV
using the standard culture conditions as above (n = 16 of 16
cells tested). We therefore sought to develop alternative
protocols that may provide the appropriate environmental
cues for synaptic maturation. First, as glial cells can play
a major role in the regulation of neuronal synaptic develop-
ment and connectivity (Eroglu and Barres, 2010), hiN cells
were cocultured with murine glial cells (obtained from mice
ubiquitously expressing red fluorescent protein) (Muzumdar
et al., 2007). After 2 weeks of coculture, whole-cell patch-
clamp recordings of hiN cells (identified as nonfluorescent
cells with a neuronal morphology) held at 70 mV revealed
spontaneous membrane current changes that were sensitive
to glutamatergic receptor inhibition with NBQX and APV
(Figures 5A–5C; n = 6 of 10 cells tested).
Second, GFP-labeled hiN cells were transplanted in utero
into embryonic day 13.5 mouse brain (Bru¨stle et al., 1997).
The transplanted cells migrated from the ventricles into
various brain regions, as expected (Figures 5D and 5E and
Table S3). The identity of GFP-positive transplanted hiN cells
was confirmed by immunostaining with an antibody specific
for human NCAM (Figure 5F). Voltage-clamp recordings from
GFP-positive hiN cells within acutely prepared brain slices from
postnatal day 7 pups demonstrated spontaneous currents of
various amplitudes and frequencies (Figure 5G; n = 3). These
events increased in frequency and amplitude upon blockade of
GABAA receptors with picrotoxin (Figure 5H) and were sup-
pressed with the glutamatergic receptor channel inhibitors
NBQX and APV (Figure 5I). We confirmed the identity of the re-
corded cell by dual fluorescence imaging (Figures S4A and
S4B). Subsequent to the recording, slices were immunostained
to demonstrate expression of the human-specific mitochondrial
marker hMito within recorded cells (Figure S4C; n = 3). Together,
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Figure 4. Electrophysiological Characterization and Evoked Calcium Transients of Cultured hiN Cells
(A) An example voltage-clamp recording from an hiN cell. Stepping the membrane voltage from80 mV to more depolarized potentials (70 to +60 mV in 10 mV
increments) resulted in fast inward currents in 18 of 22 cell analyzed. Shown are example traces between40 to 0mV. Inset illustrates the pooled current density-
voltage relationship (error bars represent the SEM).
(B) The fast inward currents were sensitive to bath application of the Na+ channel blocker tetrodotoxin (TTX, 600 nM).
(C) Outward K+ currents were obtained (in 14 of the 16 hiN cells recorded) with a KCl-based pipette solution upon depolarizing steps as described above.
(D) Minimal or no outward K+ currents were observed in cells recorded with a Cs+-based pipette solution, as expected, but note the presence of the inward
sodium currents.
(E) Macroscopic whole-cell voltage-dependent Ca2+ channel activity of hiN cells was identified using Ba2+ as the charge carrier. Currents were elicited in
response to depolarizing steps from 70 mV in 10 mV steps (in 3 of the 4 hiN cells analyzed).
(F) In current-clamp mode, hiN cells exhibited a rebound action potential (arrow) at the end of hyperpolarizing current injections and action potentials upon
depolarizing current injection. Bottom panel is a time schematic of the current injection protocol.
(G) Glutamate-mediated postsynaptic currents (PSCs) were elicited by focal application of 1 mM glutamate puffs for 50 ms in cells voltage clamped at 70 mV;
shown are three traces elicited once every 3 min.
(H) Induced PSCs were sensitive to the AMPA channel blocker NBQX (20 mM) and the NMDA blocker APV (50 mM).
(I) Focal application of GABA (50 ms puff, 1 mM) to cells voltage clamped at +20 mV and dialyzed with a low Cl solution elicited current responses; shown are
three traces evoked every 3 min.
(J) GABA-mediated currents were sensitive to the GABAA antagonist picrotoxin (50 mM). Puff applications of neurotransmitter are indicated by a solid line above
tracings.
(K) (Upper-left) Fluorescence pseudocolor image of a complex axon-like process in an hiN cell dialyzed with 100 mMof the calcium indicator OG-1 (Oregon Green
488 BAPTA-1). (Lower-left) A higher-magnification view of a segment of this process (as demarked by white square in the top panel); individual regions of interest
(ROIs) are indicated by numbered squares within the bottom panel. (Right) Time courses of the relative change in fluorescence (DF/F0) in individual ROIs, as
numbered in the lower-right panel. Calcium transients were evoked by 200ms depolarizing pulses (Vh =70 to 0mV) in the soma. ROIs #2 and #3 display calcium
transients (hot spots), but no response was elicited in ROI #1.
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Figure 5. Evidence of hiN Cell Functional Integra-
tion
(A) Representative spontaneous postsynaptic currents
recorded from an hiN cell present in a murine glial mono-
layer coculture. The cell was held at 70 mV. Events of
various amplitudes (5–20 pA) are seen.
(B) Spontaneous postsynaptic currents as observed in (A)
were abolished by bath application of NBQX/APV.
(C) Upon depolarizing current injections in current-clamp
mode, action potentials were induced. Individual traces
represent independent recorded events; action potentials
(indicated by arrows) were seen in five of the nine tracings.
(D and E) Confocal fluorescent images of brain slices
prepared from postnatal day 3 animals that had been
grafted in utero with hiN cells. Transplanted hiN cells
migrated extensively and extended neurite processes. An
arrowhead indicates cell soma; arrows point to apparent
processes. Scale bars: (D) 100 mm, (E) 20 mm.
(F) Confocal reconstruction of a transplantedGFP-positive
hiN cell stained with a human-specific NCAM antibody.
GFP, green; hNCAM, red. Scale bar, 50 mm.
(G) Voltage-clamp recording of an hiN cell (Vh = 70 mV)
integrated into the piriform cortex of the host brain,
demonstrating spontaneous events of low frequency and
amplitude.
(H) The frequency and amplitude of the spontaneous
excitatory postsynaptic currents (sEPSCs, as in G) in-
creased upon blockade of GABAA receptors with 50 mM
picrotoxin.
(I) sEPSCs were drastically reduced by blocking gluta-
matergic synaptic transmission with 20 mM NBQX and
50 mM APV.
(J) Sodium currents of the same cell (G–I) elicited by
voltage steps from Vh = 70 mV (60 to 20 in 10 mV
steps).
(K) Representative voltage-clamp recording at a holding
potential (Vh = 70 mV) of an hiN cell integrated into the
cingulate gyrus of the host brain. Traces show sponta-
neous slow and fast currents of different amplitudes,
indicating that this neuron receives synaptic contacts from
host cells.
See also Figure S4 and Table S3.ET
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neuronal connectivity.
Generation of hiN Cells from FAD and SAD Patient Skin
Fibroblasts
Asproof of principle for their utility in diseasemodeling,wegener-
ated hiN cells from a panel of human skin fibroblasts derived
from patients with familial AD (FAD) due to mutations in PSEN-1
or -2, patients with sporadic AD (SAD), or unaffected individuals
(UND; n = 3 per each group). Given the likely heterogeneity of
‘‘sporadic’’ disease and the limited number of samples examined
in our study, we subsequently focused herein on phenotypic
examination of the familial lines. hiN cells derived from disease-
RCell 146,associated fibroblasts appeared similar to
those from unaffected individuals with respect
to neuronal reprogramming characteristics,
such as efficiency of MAP2-positive hiN cell
generation and the percentage of neurons that
express vGLUT1 (Figures 1O and 1P). Inductionof expression of the mature neuron marker synaptophysin was
comparable among the hiN cell cultures, as determined by quan-
titative real time RT-PCR analysis (Figure S5A), and cell density
at 3 weeks was not significantly different across the hiN cell
cultures (Figure S5B).
APP Processing in FAD- and SAD-Derived hiN Cells
We next evaluated AD-associated phenotypes in the hiN cell
cultures, including the processing of amyloid precursor protein
(APP) to the Ab42 and Ab40 fragments. FAD patient brain is
typified by an increased Ab42/Ab40 ratio (Hardy and Selkoe,
2002). Consistent with this, the Ab42/Ab40 ratio was dramatically
increased in FAD hiN cell cultures relative to UND hiN cell359–371, August 5, 2011 ª2011 Elsevier Inc. 365
Figure 6. Modified APP Processing in FAD hiN Cell Cultures
(A) The Ab42/Ab40 ratio is selectively increased in FAD hiN cell cultures relative to UND hiN cell cultures or fibroblasts. Media from hiN cell cultures (at 3 weeks
posttransduction, empty circles) or fibroblast cultures (green circles), as indicated, was assayed for secreted Ab40 and Ab42 by sandwich ELISA. Results
represent the mean ± SEM. n = 3 individual lines per group, with 11 to 16 independent wells for each line. *p < 0.05 by ANOVA with post hoc Tukey HSD test.
(B) Total absolute extracellular Ab levels (Ab40 [white bars] + Ab42 [gray bars]) are presented for cultures as in (A). Total Ab was increased by neuronal hiN cell
conversion in the context of FAD patient cultures. In contrast, UND fibroblast cultures were not significantly different from UND hiN cell cultures. n = 3 individual
lines per group, with 11 to 16 independent wells for each line. *p < 0.05. Results represent the mean ± SEM.
(C) Quantification of total intracellular APP holoprotein using sandwich ELISA. APP is enriched in hiN cell cultures relative to fibroblast precursors (*p < 0.05 for all
comparisons.), but UND and FAD genotypes do not differ significantly. Results represent the means ± SEM (n = 6–9 wells per group). *p < 0.05.
(D) MAP2-positive neuronal cells within the hiN cultures are enriched for the Ab42 fragment, compared to fibroblastic MAP2-negative cells. FAD and UND hiN cell
cultures were immunostained with antibodies to MAP2 (left, red) along with Ab42 (right, green); nuclei are identified by Hoechst staining (blue). MAP2-negative
fibroblastic cells (demarcated with dotted lines) display low levels of Ab42 relative to the MAP2-positive cells, as quantified in Figure S5J.
(E) Accumulation of sAPPb in the media of UND and FAD cultures, as determined by sandwich ELISA. Results represent the means ± SEM; n = 4–5 wells per
individual line.
See also Figure S5.
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0.001, ANOVA with post hoc Tukey HSD; n = 3 patient lines per
FAD or UND group with 11–16 independent cultures per line).
Similarly, on a pooled analysis of all FAD hiN versus all UND hiN
cultures, the Ab42/Ab40 ratio is significantly increased in the
FAD group (p < 1 3 109; ANOVA with post hoc Tukey HSD;
n > 38 per group). The increased Ab42/Ab40 ratio is most evident
in the AG07768 line, but even in the absence of those AG07768
samples, the FAD group displayed an elevated Ab42/Ab40 ratio
(p < 1 3 109; ANOVA with post hoc Tukey HSD, n > 29 per
group). Importantly, the Ab42/Ab40 ratio in FAD hiN cell cultures
was also elevated relative to the originating FAD fibroblast
cultures (p < 1 3 109; ANOVA with post hoc Tukey HSD; n >
38 per group). In contrast, the Ab42/Ab40 ratio in UND hiN cell
cultures was not significantly elevated relative to the originating
UND fibroblast cultures (p > 0.05; ANOVA with post hoc Tukey
HSD; n>30per group). FADhiN cell conversion led to an increase
in the level of total Ab (combined Ab42 and Ab40 polypeptides)
relative to the originating FAD fibroblasts (Figure 6B; p < 0.05;
ANOVAwith post hocTukeyHSD; n= 3 individual lines per group,
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total Ab with hiN cell conversion was not apparent in the context
of UND cultures. Taken together, these data indicate that hiN cell
conversion appears to amplify an FAD-associated phenotype in
the context of PSEN1 or PSEN2 mutations.
Levels of APP holoprotein (the Ab42 and Ab40 precursor) did
not differ significantly between hiN cell cultures from FAD
patients versus UND controls, as quantified by ELISA on cellular
lysates (Figure 6C) or by quantitative real-time RT-PCR on RNA
transcripts (Figure S5C). However, in comparison to the original
fibroblast cultures, holoprotein expression was consistently
elevated with all hiN cell cultures regardless of origin (Figure 6C).
Because hiN cultures from FAD and UND genotypes displayed
similar levels of APP, it is unlikely that APP levels account for
the selective generation of Ab42 in FAD hiN cells. Using coimmu-
nostaining with antibodies to Ab42, Ab40, and MAP2, we further
observed that both isoforms of Ab are selectively increased in the
MAP2-positive neuronal cells, but not in the remaining fibro-
blastic cells, that compose the mixed hiN culture (Figures 6D
and Figures S5H–S5J).
Cleavage of APP by BACE1 b-secretase activity is thought to
be a rate-limiting step in the production of Ab and precedes
cleavage by g-secretase (Thinakaran and Koo, 2008). We thus
quantified the soluble extracellular cleavage product of APP by
BACE1, termed sAPPb, in the hiN cell cultures. There was
a consistent increase in the sAPPb product in converted FAD
and UND hiN cell cultures relative to their respective fibroblasts.
However, accumulation of sAPPb was not significantly elevated
in hiN cell cultures from FAD patients relative to hiN cell cultures
from UND individuals (Figure 6E). BACE1 transcript levels, as
determined by quantitative real-time RT-PCR, did not appear
altered in hiN cell cultures relative to fibroblasts, regardless of
disease status (Figure S5D). Thus, the elevated level of Ab42 in
hiN-FAD is not caused by increased activity of BACE1.
Altered APP-Positive Endocytic Compartment
Morphology in FAD hiN Cells
Immunocytochemical analysis of hiN cells with an antibody to
the APP amino terminus domain revealed the presence of
APP-positive puncta within soma (Figures 7A and 7B). In con-
trast, such APP-positive punctate structures were not readily
apparent in the originating fibroblasts. Quantitative analysis of
APP staining of hiN cells revealed that APP-positive puncta
(defined as 0.1 to 1 mm in diameter) are significantly increased
in FAD-derived hiN cell cultures, relative to UND hiN cells, quan-
tified in terms of total puncta area per cell (Figure 7C; FAD, 78.2 ±
10.93 mm2; UND, 23.8 ± 3.28 mm2). This is due to an increased
number of puncta per cell as well as an increased average size
of puncta (Figures S6A and S6B). Similar findings were apparent
with a second independent antibody to APP (Figure S6I). Patho-
logical studies of sporadic AD patients at autopsy have reported
evidence for alteration in the size of intracellular vesicular endo-
cytic (Cataldo et al., 1997) and lysosomal (Cataldo et al., 1996)
compartments.
APP processing by the b- and g-secretase activities may
largely proceed within vesicular endosomal compartments
(Tang, 2009). We thus further characterized the APP-positive
punctate structures in hiN cells by costaining with antibodies
for a panel of vesicular compartment and plasma membrane
markers. Subpopulations of APP-positive puncta in hiN cells
stained positively for an early endosomal marker, early endo-
some-associated antigen-1 (EEA1); a late endosomal marker,
the cation-independent mannose 6-phosphate receptor (MPR);
and a lysosomal marker, the lysosomal associated marker
protein-2 (LAMP2). Localization to the plasma membrane at
the cell periphery was also observed (quantified in terms of co-
localization at a membrane dye, CellMask). Of these popula-
tions, the EEA1-positive, APP-positive compartment was signif-
icantly increased in FAD hiN cells relative to UND cells, as
quantified by the percentage of APP-positive puncta stained
with EEA1 (Figures 7D–7F; FAD, 24% ± 2%; UND, 13% ± 1%).
In contrast, APP puncta staining at the plasma membrane
appeared significantly reduced in the FAD hiN cells (FAD-hiN,
2.1% ± 1.3%; UND-hiN, 6.3% ± 1.0%; Figures 7G–7I). APP-
positive endocytic puncta also stained for BACE1 (Figure 7J–
7L and Figure S6I; FAD, 54.2 ± 2.91 mm2; UND, 16.5 ±
0.83 mm2), as expected given the known localization of BACE1
(Vassar et al., 1999). Finally, we note that EEA1-positive and
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AMPR-positive puncta were generally enlarged in FAD cells
(Figures 7D–7F and Figures S6C–S6E), regardless of costaining
with APP, indicative of a broadly altered endocytic compart-
ment, rather than a specific defect in APP-positive structures.
We next sought to clarify whether altered APP-positive
puncta morphology in FAD-derived hiN cells might simply be a
secondary consequence of Ab accumulation. Treatment with
a g-secretase inhibitor, DAPT, which suppressed production of
Ab (Figures S6K and S6L), did not prevent increased APP-posi-
tive puncta area per cell in the context of the FAD lines (Figures
7M–7O). Rather, we found that DAPT treatment of UND hiN cells,
but not FAD hiN cells, partially phenocopied the magnified APP-
positive intracellular compartment (Figures 7M–7O). Thus, the
increased APP-positive puncta seen with DAPT of UND hiN cells
was occluded in the context of FAD hiN cell cultures (that already
harbor increased total APP-positive puncta).
Finally, to relate the altered intracellular APP-positive puncta in
FAD hiN cells to FADmutations, we performed a ‘‘rescue’’ exper-
iment by overexpressing wild-type PSEN1 into FAD PSEN1
mutant hiN cells. Although FAD mutations are dominantly in-
herited in human patients, it is well described that overexpres-
sion of PSENs leads to preferential replacement of the endoge-
nously encoded form by the exogenous overexpressed gene
product (in part, a consequence of reduced stability of the en-
dogenously encoded gene product; Thinakaran et al., 1997).
Consistent with this, we found that overexpression of wild-type
PSEN1 by transfection of a plasmid vector into hiN cell cultures
rescued the endosomal APP-positive endocytic phenotype;
transfection of this vector into UND cells did not appear to alter
intracellular APP-positive puncta staining (Figures 7P–7R).
These findings suggest that the FAD phenotype is caused, at
least in part, by abnormal endocytic function, which is depen-
dent on PSEN.
DISCUSSION
A major goal in regenerative medicine is the facile generation of
human neurons for cell replacement therapeutics or disease
modeling. The description of hiPS cell reprogramming methods
for the generation of pluripotent cells has fueled excitement in
the field. But as hiPS cell generation is complex, time con-
suming, and associated with tumorigenicity and genomic DNA
rearrangements (Pera, 2011), alternative approaches are of
interest. By comparison to hiPS cell reprogramming, hiN cell
conversion offers a more directed route to terminally differenti-
ated neurons.
Our analysis of FAD patient-derived hiN cell cultures under-
scores the potential utility of such human neuronal disease
models. hiN cells from PSEN mutant FAD patient fibroblasts
display an increased Ab42/Ab40 ratio relative to UND hiN cells,
consistent with patient brain pathology andwith the well-charac-
terized role of PSENs as essential components of the g-secre-
tase complex (Hardy and Selkoe, 2002). Surprisingly, the impact
of FAD PSEN mutations on the Ab42/Ab40 ratio was amplified
upon hiN cell conversion from fibroblasts. This suggests amodel
in which PSEN FAD mutants may alter APP processing at
multiple levels: directly through modified g-secretase activity,
as well as indirectly with altered cellular context. Consistent
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Figure 7. APP Is Enriched within Modified Endocytic Compartment Puncta in FAD hiN Cells
(A and B) APP immunostaining of hiN cells (right) derived from representative UND (A, AG07926) and FAD (B, AG09908) cultures labels punctate structures that
are typical of endocytic compartment vesicles. In contrast, control fibroblast cultures display a distinct labeling pattern, with sparse punctate morphology (left).
Insets show high-magnification views for visualization of APP-positive puncta (arrows). N, nuclei.
(C) Quantification of APP-positive total puncta area per cell (mm2, number of puncta per cell3 average puncta area) in individual UND and FAD hiN cell cultures as
labeled. Total APP-positive puncta area was significantly increased in FAD hiN cultures, relative to UND cultures, as a consequence of increased puncta size and
number. Results represent mean ± SEM (n = 12–38 cells in a total of 6 wells per group). *p < 0.05.
(D–F) Colocalization of APP-positive puncta with the early endosomal marker EEA1 in UND and FAD hiN cells. APP-positive puncta (in red) appeared partially
colocalized with EEA1 (in green), and this was most prominent in FAD (E) relative to UND (D) cultures. Colocalization was visualized as yellow in the merged
images. Inset panels present merged as well as individual staining patterns for visualization of areas, as demarcated by a blue square. (F) Quantification of APP
and EEA1 colocalization by fluorescent microscopy as in (E). Puncta are defined here as distinct signal intensities 0.1–1 mm in diameter using Image J analysis
software (NIH).
(G–I) A subset of APP-positive puncta is costained with a plasmamembrane marker at the cell periphery (PM, in green). In contrast to EEA1 costaining, peripheral
plasma membrane marker costaining appears reduced in the FAD hiN cells (H) relative to UND hiN cells (G). Insets are high-magnification views of areas
demarcated by blue squares. Arrows point to examples of APP puncta at cell cortex. Quantification of colocalization by fluorescent microscopy is shown in (I).
(J–L) Double immunostaining of hiN cells for APP and BACE1. Colocalization of APP and BACE1 was assessed in UND (J) and FAD (K) hiN cells. Quantification of
the data shows increased colocalization in the FAD cultures, consistent with the preferential localization to intracellular endocytic vesicles (L). All results represent
the means ± SEM (n = 35–48 cells in 3–6 independent wells per group). *p < 0.05.
(M–O) Enlarged APP-positive puncta in UND hiN cells treated with the g-secretase inhibitor DAPT. UND (M, AG07926) and FAD (N, AG09908) hiN cells were
treated with either vehicle (left) or DAPT (right) for 18 hr and then fixed and stained with an antibody to the APP amino terminus. Insets at lower right show high-
magnification views for visualization of enlarged APP-positive puncta. (O) Quantification revealed that g-secretase inhibitor treatment led to a significant
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with this model, we show that intracellular localization of APP
within vesicular endocytic structures is modified in the context
FAD PSEN hiN cells.
Prior pathological autopsy studies of early-stage AD patient
brain have reported the presence of altered endosomal, lyso-
somal, and autophagy compartments (Nixon and Cataldo,
2006). Furthermore, a complete deficiency of PSEN-1 and -2 in
fibroblasts can impair endosomal trafficking (Repetto et al.,
2007). However, the impact of FAD PSENmutations on neuronal
APP-positive endosomal structures has not previously been
characterized. Our analysis further indicates that g-secretase
inhibition in UND hiN cell cultures appears to mimic the APP-
positive endosomal compartment phenotype of FAD cultures,
suggesting a role for reduced g-secretase activity in this FAD
phenotype. It remains possible that FAD-associated endosomal
compartment modifications, as observed in FAD hiN cells, play
a pathogenic role in AD independent of Ab. The issue is com-
plicated by the many functionally heterogeneous FAD-associ-
ated PSEN1 and PSEN2 mutations. An important limitation to
our present study is that we evaluate only two such forms,
and thus future studies with additional lines would likely be
informative.
Examination of FAD hiN cell models for additional AD-associ-
ated pathological findings, such as defective synaptic function,
will be of interest. To this end, the ability of hiN cells to function-
ally integrate into neuronal circuitry will be particularly useful. It is
also conceivable that such integration of hiN cells into murine AD
disease models will test the therapeutic potential of hiN cells.
Finally, we note that, in the future, it may well be feasible to eval-
uate mechanisms of sporadic AD pathology using hiN cell
models.
EXPERIMENTAL PROCEDURES
Human Skin Fibroblasts
Human skin fibroblast cultures from nine individuals were used in this study
(see Table S1). All lines were derived from de-identified, banked tissue
samples. Human skin fibroblasts were cultured in standard fibroblast media
(see Extended Experimental Procedures).
Plasmid Construction and Lentiviral Production
cDNAs for the reprogramming factors were cloned into lentiviral vectors either
individually or as a polycistronic set (for Ascl1, Brn2, and Zic1; see Extended
Experimental Procedures for cloning details). Production of replication-incom-
petent lentiviral particles was as described (MacLeod et al., 2006). Human
wild-type PSEN1 cDNA (Openbiosystems) was cloned into the pLenti6.3/
V5-Dest vector using the Gateway LR cloning system (Invitrogen).
hiN Cell Induction and Transfection
Fibroblasts were transduced with replication-incompetent, VSVg-coated len-
tiviral particles encodingAscl1,Brn2,Myt1l,Oligo2, and Zic1 at amultiplicity of
infection of 2:1 and were maintained in fibroblast media for 2 days (see
Extended Experimental Procedures). Subsequently, the media was replaced
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*p < 0.05.
(P–R) Rescue of the endosomal APP-positive endocytic phenotype in PSEN1mut
cell cultures were transfected with an expression vector for human wild-type PSE
incubated for an additional 72 hr and subsequently immunostained for APP. Resul
*p < 0.05.
See also Figure S6.with glial-conditioned N2 media (GCM; DMEM/F12 with N2 supplement;
Invitrogen) containing 20 ng/ml BDNF and 20 ng/ml NT3 (Peprotech). For the
first 4 days in GCM, dorsomorphin (1 mM; Stemgent) was also supplemented.
Media was changed every 2–3 days for the duration of the culture period. For
the PSEN1 rescue study, cells were transfected with pLenti6.3/V5-Presenilin1
and pEGFP-C1 plasmids (9:1) using the Lipofectamine 2000 reagent (DNA:
LF2000 1 mg: 5 ml in each well of 24 well, Invitrogen).
Immunocytochemistry, Immunohistochemistry, and RT-PCR
Immunocytochemistry and immunohistochemistry (IHC) were performed as
previously described (MacLeod et al., 2006). Detailed antibody sources and
dilutions utilized can be found in the Extended Experimental Procedures.
Imaging was conducted by laser scanning confocal microscopy with a 633/1.4
objective (LSM510, Carl Zeiss) or epifluorescence microscope (Olympus
1X71; Japan). Cell counts and fluorescence intensities were quantified within
10–35 images of randomly selected views per well. Subsequently, images
were analyzed for cell counts and fluorescent intensity using Image J 1.42q
software (National Institute of Health, USA). Values are presented as mean ±
SEM. Quantitative real time RT-PCR was performed as described (Rhinn
et al., 2008); primer pairs utilized are detailed in the Extended Experimental
Procedures. Gene expression levels were quantified by the DDCt method
(Rhinn et al., 2008).
FACS and Transcriptome Analyses
hiN cells (106 cells) were stained with an antibody to NCAM (BD Bioscience)
and then sorted on a FACS Aria IIu (BD Bioscience, CA) directly into RNA lysis
solution (Ambion, TX). RNA was extracted from cell preparations using the
RNAqueous Micro Kit (Ambion). Concentration and quality of RNA were as-
sessed using the Bioanalyzer system (Agilent). mRNA was amplified and
labeled using Ovation Pico WTA System (Nugen) and was subsequently
hybridized to Human Genome U133 Plus 2.0 Arrays (Affymetrix). Raw data
were processed using the R statistical computing environment Affymetrix
Linear Modeling Graphical User Interface package (affylmGUI). Computational
methods are detailed in the Extended Experimental Procedures.
In Utero Transplantation
Human skin fibroblasts (STC0022) were labeled by transduction with a GFP-
encoding lentiviral vector and then passaged three times over 10 days prior
to initiation of hiN cell induction to remove residual lentivirus. hiN induction
was then performed using the lentiviral vectors encoding Ascl1, Brn2, Myt1l,
Oligo2, and Zic1, as described above. At 7–10 days later, cells were trypsi-
nized and triturated to single-cell suspensions in the presence of 0.1% DNase
(QIAGEN). Timed pregnant C57BL/6N mice at day 13.5 of gestation were
anesthetized with oxygen containing 2% isoflurane administered through an
inhalation mask, and 2–5 3 105 cells were injected into the telencephalic
vesicle of each embryo as described (Bru¨stle et al., 1997). Transplanted
mice were spontaneously delivered and analyzed at the time points indicated.
Following deep isoflurane anesthesia, mice were euthanized, and the brains
were rapidly removed and fixed in 4% paraformaldehyde for 2 days. For
IHC, 50 mm sections were cut with a vibrating blade microtome.
Electrophysiology and Calcium Imaging
Tight-seal whole-cell recordings (WCR) were performedwith borosilicate glass
pipettes (resistance 5–8 MU) using an Axopatch 200B amplifier (Axon Instru-
ments). Recordings from transplanted cells were performed in acutely
prepared brain slices (180 mm thick) through the entire cerebrum, as described
in detail (Llano and Bezanilla, 1980). For glial coculture studies, murine astro-
glial cells were prepared as previously described (Kaech and Banker, 2006)
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ant FAD hiN cells. UND (P, STC0022) and PSEN1mutant FAD (Q, AG07768) hiN
N1 or empty vector (along with EGFP to mark transfected cells). Cultures were
ts represent themean ±SEM (n = 35–50 cells in 3 independent wells per group).
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from mice ubiquitously expressing red fluorescent protein (Muzumdar et al.,
2007). For calcium imaging, Oregon Green-BAPTA 1 (OG1; Molecular Probes)
was added at a concentration of 100 mM. Fluorescent imaging was conducted
using a digital EM-CCD camera (Andor ixon) with an LED light source (Cairn).
Values are expressed as the percentage of change in fluorescence signal with
respect to prestimulus control,DF/F0 = 1003 (F F0)/(F0B), wherein F is the
fluorescence at any given time, F0 the average at the prestimulus period, and B
the average value of the background fluorescence at each time point, as quan-
tified in four regions of the imaged field that do not contain any part of the dye-
filled cell.
Sandwich ELISAs
APP ELISA was performed using a human APP ELISA kit (Invitrogen, Cama-
rillo, CA), according to the manufacturer’s instruction. Absorbance was read
on a VersaMax ELISA Microplate Reader (Molecular Devices, Inc., Sunnyvale,
CA) at 450 nm. The amount of APP was normalized to the total cell protein
(determined with the DC Protein Assay Reagent kit; Bio-Rad, Hercules, CA).
sAPPb ELISA was performed using BetaMark sAPP Beta ELISA kit (Covance,
Princeton, NJ), according to the manufacturer’s instruction. The chemilumi-
nescence was read on a microplate luminometer (SPECTRAFluoR Plus,
TECAN, Ma¨nnedorf, Switzerland). Ab quantification was performed by ELISA
as described previously (Cirrito et al., 2003).
Statistical Analysis
Statistic analyses were performed with the Ystat 2002 software (Igaku Tosho
Shuppan Co., Ltd., Tokyo, Japan) together with Microsoft Excel software
(Microsoft Corp., Redmond, WA, USA) or by using R aov and TukeyHSD func-
tions. The statistical significance of comparisons was assessed either by
ANOVA with post hoc Tukey HSD (where indicated) or by nonparametric
ANOVA Kruskal-Wallis H test, followed by post hoc Mann-Whitney U test
with Bonferroni correction.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and four tables and can be found with this article online at doi:10.
1016/j.cell.2011.07.007.
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